0
Transipeg 5.9 g powder for oral solution Bags
Over-the-counter medication

Transipeg 5.9 g powder for oral solution Bags

€3.98 EXCL. VAT €4.39 INCL. VAT
In stock
Reference : 3400934424021
You must be logged in to add this product to a list. Customer login

Order TRANSIPEG 5.9 g powder oral solution in sachets without a prescription and give your opinion, a drug recommended in the treatment of constipation.

Find the composition and dosage of TRANSIPEG 5.9 g powder oral solution in sachets in our online pharmacy bio: macrogol 3350

For warnings, precautions for use and contraindications, please consult the instructions for use of TRANSIPEG 5.9 g powder oral solution in sachets without prescription.

Description of TRANSIPEG 5.9 g powder oral solution in sachets

Indication:

  • Constipation (INDICATION)
  • Constipation (INDICATION_GROUP)
  • Palliative care (INDICATION_GROUP)

Intestinal transit
Food has a long way to go. During this gastrointestinal odyssey, which can last thirty-six hours, the food is chewed and predigested in the mouth and descends, via the esophagus, towards the stomach, propelled by undulatory movements of the esophageal wall. Located at the entrance to the stomach, the cardiac glands lubricate the food that enters it. The stomach secretes hydrochloric acid and a number of enzymes that aid in the digestion of carbohydrates, proteins and dietary lipids. Once liquefied, food slides in the direction of the duodenum and arrives in the small intestine, responsible for the end of digestion and the absorption of food products (nutrients) usable in the lymphatic system and the blood circulation.

We can speak of constipation when the stools are hard, dry and difficult to evacuate. In general, this is diagnosed below 3 bowel movements per week. Occasional constipation most often results in bloating and stomach pain , but can lead to serious complications.

Composition of this drug

Molecules:

  • 14315: TRANSIPEG 5.9 g powder for oral solution in sachets (ITEM -)
  • anhydrous sodium sulfate (MOLECULE - Excipient)
  • silicon dioxide (MOLECULE - Excipient)
  • potassium chloride (MOLECULE - Excipient)
  • sodium chloride (MOLECULE - Excipient)
  • potassium (MOLECULE - Excipient with known effect)
  • sucrose (MOLECULE - Excipient with known effect)
  • maltodextrin (MOLECULE - Excipient with known effect)
  • lemon aroma (MOLECULE - Excipient)
  • lecithin (MOLECULE - Excipient)
  • sodium bicarbonate (MOLECULE - Excipient)
  • aspartame (MOLECULE - Excipient with known effect)
  • macrogol 3350 (MOLECULE - Active Substance)
  • gum arabic (MOLECULE - Excipient)
  • sodium (MOLECULE - Excipient with known effect)
  • potassium acesulfame (MOLECULE - Excipient)

Directions for use and dosage of TRANSIPEG 5.9 g powder oral solution in sachets

Each sachet must be dissolved in 100 ml of water (i.e. a glass of water, preferably non-carbonated). Once the sachet is dissolved, take this medication quickly.

Presentation of TRANSIPEG 5.9 g powder oral solution in sachets

Transipeg comes in the form of a sachet.

Warnings on drugs that treat digestive issues

Attention, the drug TRANSIPEG 5.9 g powder oral solution in Sachets without prescription is not a product like the others. Read the package leaflet carefully before ordering. Keep medicines out of the reach of children. If symptoms persist, seek the advice of your doctor or pharmacist. Beware of incompatibilities on your current products.

  • Please inform your online pharmacist of the treatments in progress in order to identify any incompatibilities. The order validation form contains a personalized message field provided for this purpose.
  • Click here to find the package leaflet for this medication on the website of the National Agency for the Safety of Medicines and Health Products.
  • Pharmacovigilance: Declare an undesirable effect (s) linked to the use of a drug

Pharmacovigilance Report an adverse drug reaction(s)

Download PDF leaflet

NOTICE

ANSM - Updated on: 16/02/2015

Name of the medicinal product

TRANSIPEG 5.9 g, powder for oral solution in sachet

Macrogol 3350

framed

Please read this leaflet carefully before you start taking this medicine because it contains important information for you.

· Keep this leaflet. You might need to read it again.

· If you have any further questions, ask your doctor or pharmacist

· This medicine has been prescribed for you. Do not give this to anyone else. It could be harmful to them, even if the signs of their illness are the same as yours.

· If you experience any side effects, talk to your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. See section 4.

Review summary

In this notice :

1. WHAT IS TRANSIPEG 5.9 g, powder for oral solution in sachets AND WHAT CASES IS IT USED FOR?

2. BEFORE YOU TAKE TRANSIPEG 5.9 g powder for oral solution in sachet?

3. HOW TO TAKE TRANSIPEG 5.9 g, powder for oral solution in sachet?

4. WHAT ARE POSSIBLE SIDE EFFECTS?

5. HOW TO STORE TRANSIPEG 5.9 g powder for oral solution in sachet?

6. ADDITIONAL INFORMATION

1. WHAT IS TRANSIPEG 5.9 g, powder for oral solution in sachets AND WHAT CASES IS IT USED FOR?

Pharmacotherapeutic group

TRANSIPEG 5.9 g, powder for oral solution in a sachet belongs to a group of medicines called osmotic laxatives. Osmotic laxatives are drugs that keep water in your gut.

Therapeutic indications

This medication is indicated for the symptomatic treatment of constipation in adults.

2. BEFORE YOU TAKE TRANSIPEG 5.9 g powder for oral solution in sachet?

List of information needed before taking the medication

Not applicable.

Cons-indications

Do not take TRANSIPEG 5.9 g, powder for oral solution in sachet:

· If you are allergic (hypersensitive) to the active ingredient (macrogol 3350) or any of the other ingredients of TRANSIPEG 5.9 g, powder for oral solution in sachet ( see section "6. Additional Information" ).

· If you have a bowel disease (and especially a colon).

· If you have a perforation or if you are going to puncture your gut.

· If you have pain in your tummy.

· If you have a hereditary disease called phenylketonuria because TRANSIPEG 5.9 g, powder for oral solution contains aspartame ( see also "Important information about some of the ingredients of TRANSIPEG 5.9 g, powder for oral solution in sachet " ).

If in doubt, it is essential to seek the advice of your doctor or pharmacist.

Precautions for use; special warnings

Take special care with TRANSIPEG 5.9 g powder for oral solution in sachet:

If you are using this medication for the first time and you are not getting better after 2 weeks of treatment, ask your doctor.

TRANSIPEG 5.9 g, powder for oral solution in sachet and constipation:

Occasional constipation : It may be related to a recent change in lifestyle (eg travel). TRANSIPEG 5.9 g, powder for oral solution in sachet can be a short treatment aid. You should consult your doctor for any recent constipation that is not due to a change in lifestyle or for any constipation accompanied by pain, fever or swelling of the belly.

Chronic constipation (long-lasting constipation) : It can be related to two causes:

· Either you suffer from a bowel disease. Your doctor will then prescribe a specific treatment for this situation;

· Either you have an imbalance in your intestine related to your eating habits and your lifestyle.

The treatment of your constipation should be accompanied by the following recommendations on your eating habits and lifestyle:

· an increase in vegetable fibers (green vegetables, raw vegetables, whole bread, fruits ...) in your diet;

· increased consumption of water and fruit juices;

· an increase in physical activities (sports, walking, etc.);

· rehabilitation of the defecation reflex;

· sometimes, adding sound to your diet.

It is important to consult a doctor if there is no improvement.

Interaction with other medicines

Taking or using other medicines:

If you are taking or have recently taken any other medicines, including medicines obtained without a prescription, talk to your doctor or pharmacist.

Interactions with food and beverages

Not applicable.

Interactions with Herbal Medicines or Alternative Therapies

Not applicable.

Use during pregnancy and lactation

Pregnancy

TRANSIPEG 5.9 g powder for oral solution in sachet can be used during pregnancy only on the advice of your doctor.

If you discover that you are pregnant during treatment, consult your doctor as he alone can judge the need to continue.

feeding

TRANSIPEG 5.9 g, powder for oral solution in sachets can be used during breast-feeding.

Ask your doctor or pharmacist for advice before taking any medicine.

Sport

Not applicable.

Effects on ability to drive or use machines

Not applicable.

List of excipients with known effect

Important information about some of the ingredients of TRANSIPEG 5.9 g powder for oral solution in sachet:

TRANSIPEG 5.9 g, powder for oral solution contains several ingredients you should consider before using this medicine:

· of aspartam (source of phenylalanine). It can be dangerous for people with a hereditary disease called phenylketonuria.

· of sucrose. If your doctor has told you about an intolerance to some sugars, contact your doctor before taking this medicine.

· of sodium (290 mg per sachet). You should consider this if you are on a salt-free or low-salt diet.

· potassium (about 40 mg per sachet). You should consider this if you have kidney failure or if you are on a controlled potassium diet.

3. HOW TO TAKE TRANSIPEG 5.9 g, powder for oral solution in sachet?

Instructions for proper use

TRANSIPEG 5.9 g powder for oral solution in sachets should be taken only for a short period of time.

The effect of TRANSIPEG 5.9 g, powder for oral solution in a sachet is manifested within 24 to 48 h after setting.

Dosage, Mode and / or route (s) of administration, Frequency of administration and Duration of treatment

Dosage

Always take the dose recommended by your doctor. In case of doubt consult your doctor or pharmacist.

The usual dose is 1 to 2 sachets per day to be taken at one time, preferably in the morning.

Method of administration

TRANSIPEG 5.9 g, powder for oral solution in sachet is used orally. Each sachet must be dissolved in 100 ml of water (half a glass of water, preferably non-gaseous). Once the sachet is dissolved, take this medication quickly.

If you feel that the effect of TRANSIPEG 5.9 g powder for oral solution is too strong or too weak, talk to your doctor or pharmacist.

Symptoms and Instructions for Overdose

If you take more than TRANSIPEG 5.9 g powder for oral solution in a sachet you should:

Consult your doctor or pharmacist immediately ( see also section "4. What are the possible side effects?" ).

Instructions for omission of one or more doses

If you forget to take TRANSIPEG 5.9 g, powder for oral solution in sachet:

Do not take a double dose to make up for the single dose you have forgotten to take.

Risk of withdrawal syndrome

Not applicable.

4. WHAT ARE POSSIBLE SIDE EFFECTS?

Description of adverse reactions

Like all medicines, TRANSIPEG 5.9 g powder for oral solution in a sachet is liable to have undesirable effects, although not everyone is subject to it.

· Very rare cases of anaphylactic reactions (severe allergic reaction causing breathing difficulties, swelling) and allergic to urticaria (red patches), rash, pruritus (itching) or edema (swelling) have been reported reported. If these reactions occur, stop treatment immediately and seek advice from your doctor.

· Abdominal pain and bloating have also been reported frequently, especially in patients with intestinal disorders.

· The occurrence of mild to moderate diarrhea or fluid stools is a common side effect, especially in the case of a high dose.

These effects generally disappear within 24 to 48 hours after discontinuation of therapy. The treatment can then be resumed at a lower dose.

Declaration of side effects

If you experience any side effects, talk to your doctor or pharmacist. This also applies to any side effects not mentioned in this leaflet. You can also report adverse reactions directly through the national reporting system : National Agency for the Safety of Medicines and Health Products (Ansm) and network of Regional Centers of Pharmacovigilance. Website: www.ansm.sante.fr .

By reporting adverse reactions, you are helping to provide more information about the safety of the drug.

5. HOW TO STORE TRANSIPEG 5.9 g powder for oral solution in sachet?

Keep out of the reach and sight of children.

Expiration date

Do not use TRANSIPEG 5.9 g powder for oral solution in sachets after the expiry date stated on the carton. The expiry date refers to the last day of the month.

Storage conditions

No special storage conditions.

If necessary, warnings against visible signs of deterioration

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist what to do with unused medications. These measures will help protect the environment.

6. ADDITIONAL INFORMATION

Full list of active substances and excipients

What does TRANSIPEG contain 5.9 g, powder for oral solution in sachets?

The active substance is macrogol 3350 (5.9 g per sachet).

The other ingredients are sodium chloride, anhydrous sodium sulfate (E514), potassium chloride (E508), sodium bicarbonate (E500), aspartame (E951), potassium acesulfame, aroma lemon.

The lemon flavor contains: maltodextrin, sucrose, lemon flavor, gum arabic (E414), lecithin (E322) and silicon dioxide (E551).

Pharmaceutical form and content

What is TRANSIPEG 5.9 g, powder for oral solution in sachet and contents of the pack?

This medication is in the form of white to whitish powder to be dissolved in water. This medication is packaged in boxes containing 10, 20, 30, 50, 60 or 200 sachets.

Not all pack sizes may be marketed.

Name and address of the marketing authorization holder and the holder of the manufacturing authorization responsible for the release of the lots, if different

Holder

BAYER HEALTHCARE SAS

220 AVENUE OF RESEARCH

59120 LOOS

exploiting

BAYER HEALTHCARE SAS

33 STREET OF INDUSTRY

74240 GAILLARD

Maker

LABORATORIES M. RICHARD

RUE DU PROGRES

ZI OF REYS DE SAULCE

26270 SAULCE -SUR-RHONE

or

LAMPS. PROSPERO SPA

Via Della Pace, 25 / A

41030 SAN PROSPERO (MO)

Italy

Names of the medicinal product in the Member States of the European Economic Area

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

In accordance with the regulations.

Date of approval of the notice

The last date on which this leaflet was approved is {date}.

AMM under exceptional circumstances

Not applicable.

Internet Information

Detailed information on this medicine is available on the ANSM website (France).

Information for health professionals only

Not applicable.

Other

Not applicable.

VIDAL OF THE FAMILY

Transipeg

Osmotic laxative

macrogol

. Presentations . Composition . Indications . Contraindications . Warning . Pregnancy and breastfeeding . Directions for use and dosage . Advice . Undesirable effects . Lexicon

PRESENTATIONS (summary)

TRANSIPEG 2.95 g: powder for oral solution (lemon flavoring); box of 30 bags.
Refunded at 30%. - price: 3,88 euro (s).

TRANSIPEG 5.9 g: powder for oral solution (lemon flavoring); box of 20 bags.
Refunded at 30%. - price: 2,85 euro (s).

Laboratory

COMPOSITION (summary)
p sachet p sachet
Macrogol (polyethylene glycol) 3350 2.95 g 5.9 g
Sodium 145 mg 290 mg
aspartame + +

INDICATIONS (summary)
This medicine contains an osmotic laxative . It attracts water into the intestine and increases stool volume.
It is used in the symptomatic treatment of constipation in adults.
CONTRAINDICATIONS (summary)
This medication should not be used in the following cases:
  • inflammatory bowel disease,
  • intestinal occlusion or condition predisposing to occlusion,
  • abdominal pain of unknown cause,
  • phenylketonuria (presence of aspartame).
WARNING (Contents)
In case of repetitive or prolonged abdominal pain, this medication should not be taken without medical advice.
PREGNANCY AND BREAST-FEEDING (summary)
This medicine contains only presumed safe substances during pregnancy or lactation. However, do not use it prolonged without the advice of your pharmacist or doctor.
DIRECTIONS FOR USE AND DOSAGE (summary)
The contents of the sachet must be diluted in half a glass of water.
The laxative effect occurs 24 to 48 hours after taking the medication.

Usual dosage:

  • Adult: 1 to 4 sachets to 2.95 g or 1 or 2 sachets to 5.9 g per day, in 1 dose, in the morning.
TIPS (summary)
The treatment of constipation is essentially based on hygiene measures: high-fiber food, abundant drinks, regular physical activity and time to get to the saddle.
POSSIBLE ADVERSE EFFECTS (summary)
Abdominal pain.
Diarrhea in case of overdose .
Rarely: allergic reaction ( urticaria , edema ).


GLOSSARY (summary)


osmotic laxative
Laxative to make stools more liquid by retaining water in the contents of the intestine. It is devoid of toxicity.


edema
Accumulation of water or lymph causing localized swelling.


phenylketonuria
An inherited disease that is characterized by the absence of an enzyme and that leads to the accumulation in the blood of a toxic product. Screening is systematic at birth. Treatment is based on a specific diet during early childhood.


allergic reaction
Reaction due to hypersensitivity of the organism to a drug. Allergic reactions can take a wide variety of aspects: urticaria, angioedema, eczema, eruption of pimples resembling measles, etc. Anaphylactic shock is a generalized allergic reaction that causes discomfort due to a sudden drop in blood pressure.


overdose
Excessive intake of a drug may result in an increase in the intensity of adverse effects or even in the development of specific adverse effects.
This overdose may result from accidental or voluntary poisoning for suicide, so consult your local Poison Control Center (listed in the appendix to the book). However, in most cases, overdose is the result of an error in the understanding of the prescription, or the search for an increase in efficacy by exceeding the recommended dosage. Finally, untimely self-medication may lead to excessive absorption of the same substance contained in different drugs. Some drugs are particularly prone to this risk because they are (wrongly) considered to be harmless: vitamins A and D, aspirin, etc. Stopping or decreasing drug intake helps to remove the disorders associated with an overdose.


symptomatic treatment
Treatment that suppresses or alleviates the symptoms of a disease without addressing its cause.


urticaria
Eruption of pimples on the skin, whose origin is mostly allergic. The buds look like nettles and their color varies from pale pink to red.

Our doctors of pharmacy advise you

RELATED SEARCHES WITH PRODUCTS TO COMPLETE